Figure 5
From: Tocotrienols are good adjuvants for developing cancer vaccines
Tumour size of the tumours induced in the control, TRF alone, DC+TL, DC+TRF and DC+TL+TRF groups were measured. The DC+TL group were injected with DC that has been primed with tumour lysate from 4T1 cells and received daily oral supplementation of carrier oil while the DC+TL+TRF group were injected with DC primed with tumour lysate from 4T1 cells and supplemented daily with 1 mg/ml TRF orally. For the TRF alone, mice were only supplemented with TRF oil daily and for DC+TRF, DC fresh without tumour lysate and supplemented with TRF oil daily.